Demjanjuk back in jail after treatment for gout - Monsters and Critics.com

Washington Post

Demjanjuk back in jail after treatment for gout Monsters and Critics.com Munich - John Demjanjuk, the 89-year-old man accused of herding Jews to gas chambers at a Nazi death camp in 1943, returned to a German jail on Wednesday after three days of hospital treatment for gout, his lawyer in Munich said. ... Demjanjuk 'in hospital with gout' BBC News all 87 news articles

Savient to Present Multiple Abstracts At the European League ... - GlobeNewsWire (press release)

Savient to Present Multiple Abstracts At the European League ... GlobeNewsWire (press release), CA Treatment failure gout occurs in patients with gout who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with urate-lowering therapy at the maximum medically appropriate dose or for whom those drugs are ... CORRECT: Savient Up As Investors More Confident In Drug Approval Wall Street Journal all 6 news articles

XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach ... - GlobeNewsWire (press release)

XOMA 052 Clinical Results Support Novel Anti-Inflammatory Approach ... GlobeNewsWire (press release), CA XOMA 052 binds strongly to interleukin-1 beta (IL-1 beta), a pro-inflammatory cytokine involved in the development of Type 2 diabetes, cardiovascular disease, rheumatoid arthritis, gout and other diseases. By binding to IL-1 beta, the drug inhibits the ... Friday's BioPlay: Xoma Ltd. (Nasdaq:XOMA) OfficialWire all 27 news articles

Savient Announces Election of Dr. Ginger D. Constantine to Board ... - GlobeNewsWire (press release)

Savient Announces Election of Dr. Ginger D. Constantine to Board ... GlobeNewsWire (press release), CA Savient's product development candidate, KRYSTEXXA(tm) (pegloticase) for treatment failure gout has reported positive Phase 1, 2 and 3 clinical data. The KRYSTEXXA Phase 3 clinical studies were completed in October 2007; the BLA was filed with the FDA ...